FDA Inspection 1008996 — Andrew Holden, M.D.
The FDA completed an inspection of Andrew Holden, M.D. on Apr 7, 2017 in Auckland. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 7, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Auckland (New Zealand)
Additional details
Clinical Investigator (CI)